Literature DB >> 11391482

Etiological point mutations in the hereditary multiple exostoses gene EXT1: a functional analysis of heparan sulfate polymerase activity.

P K Cheung1, C McCormick, B E Crawford, J D Esko, F Tufaro, G Duncan.   

Abstract

Hereditary multiple exostoses (HME), a dominantly inherited genetic disorder characterized by multiple cartilaginous tumors, is caused by mutations in members of the EXT gene family, EXT1 or EXT2. The corresponding gene products, exostosin-1 (EXT1) and exostosin-2 (EXT2), are type II transmembrane glycoproteins which form a Golgi-localized heterooligomeric complex that catalyzes the polymerization of heparan sulfate (HS). Although the majority of the etiological mutations in EXT are splice-site, frameshift, or nonsense mutations that result in premature termination, 12 missense mutations have also been identified. Furthermore, two of the reported etiological missense mutations (G339D and R340C) have been previously shown to abrogate HS biosynthesis (McCormick et al. 1998). Here, a functional assay that detects HS expression on the cell surface of an EXT1-deficient cell line was used to test the remaining missense mutant exostosin proteins for their ability to rescue HS biosynthesis in vivo. Our results show that EXT1 mutants bearing six of these missense mutations (D164H, R280G/S, and R340S/H/L) are also defective in HS expression, but surprisingly, four (Q27K, N316S, A486V, and P496L) are phenotypically indistinguishable from wild-type EXT1. Three of these four "active" mutations affect amino acids that are not conserved among vertebrates and invertebrates, whereas all of the HS-biosynthesis null mutations affect only conserved amino acids. Further, substitution or deletion of each of these four residues does not abrogate HS biosynthesis. Taken together, these results indicate that several of the reported etiological mutant EXT forms retain the ability to synthesize and express HS on the cell surface. The corresponding missense mutations may therefore represent rare genetic polymorphisms in the EXT1 gene or may interfere with as yet undefined functions of EXT1 that are involved in HME pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11391482      PMCID: PMC1226048          DOI: 10.1086/321278

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  63 in total

1.  Cytoskeletal abnormalities in chondrocytes with EXT1 and EXT2 mutations.

Authors:  M A Bernard; D A Hogue; W G Cole; T Sanford; M B Snuggs; D Montufar-Solis; P J Duke; D D Carson; A Scott; W B Van Winkle; J T Hecht
Journal:  J Bone Miner Res       Date:  2000-03       Impact factor: 6.741

2.  Comparison of fluorescent single-strand conformation polymorphism analysis and denaturing high-performance liquid chromatography for detection of EXT1 and EXT2 mutations in hereditary multiple exostoses.

Authors:  C Dobson-Stone; R D Cox; L Lonie; L Southam; M Fraser; C Wise; F Bernier; S Hodgson; D E Porter; A H Simpson; A P Monaco
Journal:  Eur J Hum Genet       Date:  2000-01       Impact factor: 4.246

3.  Association of EXT1 and EXT2, hereditary multiple exostoses gene products, in Golgi apparatus.

Authors:  S Kobayashi; K Morimoto; T Shimizu; M Takahashi; H Kurosawa; T Shirasawa
Journal:  Biochem Biophys Res Commun       Date:  2000-02-24       Impact factor: 3.575

Review 4.  Molecular basis of multiple exostoses: mutations in the EXT1 and EXT2 genes.

Authors:  W Wuyts; W Van Hul
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

5.  The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate.

Authors:  C McCormick; G Duncan; K T Goutsos; F Tufaro
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

6.  Structural analysis of glycosaminoglycans in Drosophila and Caenorhabditis elegans and demonstration that tout-velu, a Drosophila gene related to EXT tumor suppressors, affects heparan sulfate in vivo.

Authors:  H Toyoda; A Kinoshita-Toyoda; S B Selleck
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

7.  EXT genes are differentially expressed in bone and cartilage during mouse embryogenesis.

Authors:  D Stickens; D Brown; G A Evans
Journal:  Dev Dyn       Date:  2000-07       Impact factor: 3.780

8.  A direct interaction between EXT proteins and glycosyltransferases is defective in hereditary multiple exostoses.

Authors:  A D Simmons; M M Musy; C S Lopes; L Y Hwang; Y P Yang; M Lovett
Journal:  Hum Mol Genet       Date:  1999-11       Impact factor: 6.150

9.  EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas.

Authors:  J V Bovée; A M Cleton-Jansen; W Wuyts; G Caethoven; A H Taminiau; E Bakker; W Van Hul; C J Cornelisse; P C Hogendoorn
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

10.  Identification of a receptor for reg (regenerating gene) protein, a pancreatic beta-cell regeneration factor.

Authors:  S Kobayashi; T Akiyama; K Nata; M Abe; M Tajima; N J Shervani; M Unno; S Matsuno; H Sasaki; S Takasawa; H Okamoto
Journal:  J Biol Chem       Date:  2000-04-14       Impact factor: 5.157

View more
  23 in total

Review 1.  The link between heparan sulfate and hereditary bone disease: finding a function for the EXT family of putative tumor suppressor proteins.

Authors:  G Duncan; C McCormick; F Tufaro
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

2.  Genetic analysis of hereditary multiple exostoses in Tunisian families: a novel frame-shift mutation in the EXT1 gene.

Authors:  Sana Sfar; Abderrazak Abid; Wijden Mahfoudh; Houyem Ouragini; Farah Ouechtati; Sonia Abdelhak; Lotfi Chouchane
Journal:  Mol Biol Rep       Date:  2008-03-11       Impact factor: 2.316

3.  Heparan sulfate antagonism alters bone morphogenetic protein signaling and receptor dynamics, suggesting a mechanism in hereditary multiple exostoses.

Authors:  Christina Mundy; Evan Yang; Hajime Takano; Paul C Billings; Maurizio Pacifici
Journal:  J Biol Chem       Date:  2018-04-05       Impact factor: 5.157

Review 4.  The pathogenic roles of heparan sulfate deficiency in hereditary multiple exostoses.

Authors:  Maurizio Pacifici
Journal:  Matrix Biol       Date:  2017-12-24       Impact factor: 11.583

5.  Detection of exostosin glycosyltransferase gene mutations in patients with non-hereditary osteochondromas of the mandibular condyle.

Authors:  Qin Zhou; Chi Yang; Min-Jie Chen; Ling-Zhi Li
Journal:  Mol Clin Oncol       Date:  2016-07-08

6.  General Base Swap Preserves Activity and Expands Substrate Tolerance in Hedgehog Autoprocessing.

Authors:  Jing Zhao; Daniel A Ciulla; Jian Xie; Andrew G Wagner; Drew A Castillo; Allison S Zwarycz; Zhongqian Lin; Seth Beadle; José-Luis Giner; Zhong Li; Hongmin Li; Nilesh Banavali; Brian P Callahan; Chunyu Wang
Journal:  J Am Chem Soc       Date:  2019-11-07       Impact factor: 15.419

7.  A mouse model of osteochondromagenesis from clonal inactivation of Ext1 in chondrocytes.

Authors:  Kevin B Jones; Virginia Piombo; Charles Searby; Gail Kurriger; Baoli Yang; Florian Grabellus; Peter J Roughley; Jose A Morcuende; Joseph A Buckwalter; Mario R Capecchi; Andrea Vortkamp; Val C Sheffield
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

8.  Identification of mutations in TMEM5 and ISPD as a cause of severe cobblestone lissencephaly.

Authors:  Sandrine Vuillaumier-Barrot; Céline Bouchet-Séraphin; Malika Chelbi; Louise Devisme; Samuel Quentin; Steven Gazal; Annie Laquerrière; Catherine Fallet-Bianco; Philippe Loget; Sylvie Odent; Dominique Carles; Anne Bazin; Jacqueline Aziza; Alix Clemenson; Fabien Guimiot; Maryse Bonnière; Sophie Monnot; Christine Bole-Feysot; Jean-Pierre Bernard; Laurence Loeuillet; Marie Gonzales; Koryna Socha; Bernard Grandchamp; Tania Attié-Bitach; Férechté Encha-Razavi; Nathalie Seta
Journal:  Am J Hum Genet       Date:  2012-12-07       Impact factor: 11.025

9.  Assessing the general population frequency of rare coding variants in the EXT1 and EXT2 genes previously implicated in hereditary multiple exostoses.

Authors:  Diana L Cousminer; Alexandre Arkader; Benjamin F Voight; Maurizio Pacifici; Struan F A Grant
Journal:  Bone       Date:  2016-09-09       Impact factor: 4.398

10.  Correction of knee and ankle valgus in hereditary multiple exostoses using the Ilizarov apparatus.

Authors:  E Ofiram; S Eylon; S Porat
Journal:  J Orthop Traumatol       Date:  2008-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.